Ketospray (Ketoprofen)

Ketoprofen blocks the cyclo‑oxygenase‑1 and cyclo‑oxygenase‑2 enzymes, which are essential for prostaglandin production. By lowering prostaglandin levels at the site of application, it reduces vascular leakage, swelling, and the activation of pain‑sensing nerves, providing analgesic and anti‑inflammatory effects.

The specific dose and frequency of Ketospray are determined by the prescribing clinician based on the patient’s condition, severity of symptoms, and treatment goals. The prescriber will provide detailed instructions on how much spray to apply and how often.

Ketospray is not recommended during the third trimester of pregnancy because NSAIDs may affect fetal cardiovascular development. For breastfeeding mothers, the potential for ketoprofen to pass into breast milk exists, so a healthcare professional should evaluate the risk‑benefit balance before use.

To request Ketospray, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain needs) and necessary import documentation.

Ketospray delivers ketoprofen directly to the skin, offering targeted pain relief with lower systemic exposure compared with oral NSAIDs such as ibuprofen or diclofenac. This topical route can reduce the risk of gastrointestinal side effects while still providing effective anti‑inflammatory action for localized conditions.

Ketospray should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed when not in use.

Ketospray is applied topically to the affected area. The prescriber will advise the amount to spray, typically a measured number of pumps, and the frequency (e.g., two to three times daily). The skin should be clean and dry before application, and hands should be washed after use.

Serious risks include severe allergic reactions such as anaphylaxis, Stevens‑Johnson syndrome or toxic epidermal necrolysis, and significant liver or kidney impairment in susceptible individuals. Any signs of widespread rash, swelling, breathing difficulty, or unusual fatigue should prompt immediate medical attention.

Ketospray should not be used by individuals with known hypersensitivity to ketoprofen or other NSAIDs, those who have experienced asthma, urticaria, or allergic reactions after NSAID exposure, and patients in the third trimester of pregnancy. Consultation with a healthcare professional is essential for anyone with existing liver, kidney, or cardiovascular disease.